MicrobiologybioRxiv
In vitro evaluation of therapeutic antibodies against a SARS-CoV-2 Omicron B.1.1.529 isolate
F. Touret, C. Baronti, H. S. Bouzidi, X. de Lamballerie
The paper evaluates the neutralizing activity of eight therapeutic antibodies against an Omicron SARS-CoV-2 isolate and finds significant loss of efficacy for most, with only Sotrovimab showing minimal reduction.
DOI 10.1038/s41598-022-08559-5